Ibuprofen API Market is estimated to progress at a CAGR

According to the findings of a new Future Market Insights (FMI) report, the global Ibuprofen API Market crossed US$ 626.2 Million in 2022 and is expected to grow at a CAGR of 3% to reach US$ 772.2 Million by 2029. The key drivers of the Ibuprofen API market are the ongoing need for low-cost nonsteroidal anti-inflamm...

Related Keywords

China , Delaware , United States , New York , Jingmen , Guangxi , India , Zibo , Shandong , America , , Hubei Biocause Heilen Pharmaceutical Co , Gsi Group Inc , Granules India , Sino Us Zibo Xinhua Perrigo Pharmaceutical Co Ltd , Granules India Ltd , Market Insights Inc , Solara Active Pharma Sciences , Companies Profiled In Ibuprofen , Greater New York Chamber , Industry Research , Hubei Biocause Pharmaceutical Co Ltd , Future Market Insights , For Report , Companies Profiled , Questions Related , North America , Manufacturing Organizations , South Asia , Strategic Mergers , Widen Regional , Solara Active Pharma Sciences Limited , Indian Ibuprofen , Active Pharma Sciences Limited , India Ltd , Hubei Biocause Heilen Pharmaceutical , Market Insights , Sales Channel , End Use , Sales Enquiries , All Reports ,